Clinical outcomes in children with Henoch-SchÖnlein purpura nephritis grade IIIa or IIIb

Pediatric Nephrology

Volumn 26, Issue 7, 2011, Pages 1083-1088

  Xia, Yonghui ^a   Mao, Jianhua ^a   Chen, Yifang ^a   Wang, Dayan ^a   Cao, Lu ^a   Yao, Shenhua ^a   Fu, Haidong ^a   Du, Lizhong ^a   Liu, Ai'min ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Child; Clinical; Henoch Sch nlein purpura nephritis; Pathology; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRIPTOLIDE;

ANAPHYLACTOID PURPURA; BONE NECROSIS; CATARACT; CHILD; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; GLAUCOMA; GROWTH RETARDATION; HEMATURIA; HENOCH SCHONLEIN PURPURA NEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN DEPOSITION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY BIOPSY; LEUKOPENIA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD;

ADOLESCENT; BIOPSY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHINA; DITERPENES; DRUG THERAPY, COMBINATION; EPOXY COMPOUNDS; FEMALE; HEMATURIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHRITIS; NEPHROTIC SYNDROME; PHENANTHRENES; PREDNISONE; PROTEINURIA; PURPURA, SCHOENLEIN-HENOCH; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052456192     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1834-9     Document Type: Review

References (18)

1. Shenoy M, Bradbury MG, Lewis MA, Webb NJ (2007) Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22:1717-1722. (Pubitemid 47337426)
2. Bogdanovic R (2009) Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr 98:1882-1889.
3. Assadi F (2009) Childhood Henoch-Schönlein nephritis: a multivariate analysis of clinical features and renal morphology at disease onset. Iran J Kidney Dis 3:17-21.
4. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H (2003) Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 111:785-789. (Pubitemid 36402902)
5. Tarshish P, Bernstein J, Edelmann CM Jr (2004) Henoch- Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 19:51-56. (Pubitemid 38088250)
6. Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 19:858-864. (Pubitemid 38455656)
7. Ronkainen J, Autio-Harmainen H, Nuutinen M (2003) Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis. Pediatr Nephrol 18:1138-1142. (Pubitemid 37406861)
8. Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238-243. (Pubitemid 28204133)
9. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244-248. (Pubitemid 28204134)
10. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11-14.
11. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33:1114-1121. (Pubitemid 20273296)
12. Meadow SR, Glasgow EF, White RH, Moncrieff MW, Cameron JS, Ogg CS (1972) Schönlein-Henoch nephritis. Q J Med 41:241-258.
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576.
14. Gao Q, Shen W, Qin W, Zheng C, Zhang M, Zeng C, Wang S, Wang J, Zhu X, Liu Z (2010) Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant 25:3539-3547.
15. Xu G, Tu W, Jiang D, Xu C (2009) Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis. Nephron Clin Pract 111:c223-228.
16. Tao X, Lipsky PE (2000) The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 26:29-50, viii. (Pubitemid 30091720)
17. Jiang X (1994) Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome. Pediatr Nephrol 8:343-344. (Pubitemid 24162277)
18. Chen YZ, Gao Q, Zhao XZ, Chen XM, Zhang F, Chen J, Xu CG, Sun LL, Mei CL (2010) Meta-analysis of Tripterygium wilfordii hook F in the immunosuppressive treatment of IgA nephropathy. Intern Med 49:2049-2055.